Prevention and Treatment of Staphylococcus aureus Biofilms Using Promising Agr-QS-Targeting Anti-Biofilm Agents
Pathogens · 27.07.2026 · 15 (8) · 795
DOI: 10.3390/pathogens15080795 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pathogens, online erschienen am 27.07.2026. Verfasst von Salma Waheed Sheikh und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biological Sciences, Texas Tech University, Lubbock, TX 79409, USA. Hauptthemen laut MEDLINE: Biofilms, Quorum Sensing, Anti-Bacterial Agents, Staphylococcal Infections. Die Arbeit nennt 289 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Texas Tech Association of Biologists, TechASM, Texas Tech University Association of Biologists and TechASM.
Abstract (Originalsprache)
Staphylococcus aureus (S. aureus), a leading cause of nosocomial infections, contributes significantly to increased morbidity and mortality, especially when it forms biofilms on medical devices. This pathogen, specifically methicillin-resistant S. aureus (MRSA), remains a challenge to treat due to its ability to form biofilms and rapidly develop resistance against antibiotics. Biofilm formation allows bacteria to adhere to biotic and abiotic surfaces, creating a protective matrix that shields them from immune responses and antibiotic therapies. The widespread prevalence of multidrug-resistant S. aureus biofilms poses a significant therapeutic challenge in clinical settings. Several novel therapeutic strategies have been developed to combat S. aureus biofilm-associated infections. Accumulating evidence suggests that natural plants and their derivatives possess antimicrobial and chemo preventive properties that can disrupt established biofilms. Several plant-derived compounds with anti-biofilm activities have been reported to target the regulatory proteins involved in the Agr quorum sensing (Agr-QS) system, underscoring their potential as therapeutic candidates for the prevention and treatment of biofilm-associated infections. However, despite these encouraging findings, clinical validation of these plant-based agents is essential to ensure their efficacy, safety, and optimal application in treating S. aureus biofilm infections. The continued exploration of natural biofilm inhibitors anticipates the urgent need for new treatments to combat biofilm-associated infections and multidrug-resistant pathogens like MRSA. This review provides a detailed overview of preventive and therapeutic interventions to eradicate biofilm-forming S. aureus infections.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biological Sciences, Texas Tech University, Lubbock, TX 79409, USA.
- Medical School, Twin Cities Campus, University of Minnesota, Twin Cities, Minneapolis, MN 55455, USA.
- School of Life Sciences, Anhui Agricultural University, Hefei 230036, China.
ORCID-Profile: Ting Xue, Lauren Gollahon
Förderung
- Texas Tech Association of Biologists
- TechASM
- Texas Tech University Association of Biologists and TechASM
Zitieren
APA
Sheikh, S. W., Ali, A., Ahsan, A., Shang, F., Xue, T., & Gollahon, L. (2026). Prevention and Treatment of Staphylococcus aureus Biofilms Using Promising Agr-QS-Targeting Anti-Biofilm Agents. Pathogens, 15(8), 795. https://doi.org/10.3390/pathogens15080795
Vancouver
Sheikh SW, Ali A, Ahsan A, Shang F, Xue T, Gollahon L. Prevention and Treatment of Staphylococcus aureus Biofilms Using Promising Agr-QS-Targeting Anti-Biofilm Agents. Pathogens. 2026;15(8):795. doi:10.3390/pathogens15080795
BibTeX
@article{Sheikh2026,
author = {Sheikh, Salma Waheed and Ali, Ahmad and Ahsan, Asma and Shang, Fei and Xue, Ting and Gollahon, Lauren},
title = {Prevention and Treatment of Staphylococcus aureus Biofilms Using Promising Agr-QS-Targeting Anti-Biofilm Agents},
journal = {Pathogens},
year = {2026},
volume = {15},
number = {8},
pages = {795},
doi = {10.3390/pathogens15080795}
}
EUVIMED